The inaugural Prop Masters Guild MacGuffin Awards celebrated the achievements of the artisans who make Hollywood sets come to ...

Oppenheimer started coverage of Dianthus Therapeutics (NASDAQ:DNTH) with an outperform rating, citing the market potential of ...

Derek Hunt, who inherited the adjoining Sable Ranch and Rancho Maria from his grandfather, Frank Vacek, has put them up for ...

We look at prior dramatizations of this very complicated man—including one wherein J. Robert Oppenheimer played himself!—and examine why they worked or didn't. In the episode: ...

Oppenheimer analyst Scott Schneeberger maintained a Buy rating on XPO (XPO – Research Report) today and set a price target of $140.00.

Oppenheimer has recently initiated Cadence Design Systems Inc (CDNS) stock to Underperform rating, as announced on September 25, 2024, according to Finviz. Earlier, on August 6, 2024, Piper Sandler ...

(JTA) — Friday is not just “Barbie” release day — moviegoers are also planning to fill theaters across the United States to see Christopher Nolan’s “Oppenheimer” biopic. Many hope it ...

Cillian Murphy once shared his “Catholic guilt” for making $10 million from Christopher Nolan’s Oppenheimer, admitting he ...

After playing multiple supporting roles in Christopher Nolan films, Cillian Murphy delivered a smashing performance playing ...

The acclaimed documentarian discusses his first narrative feature and shares some strong words about the upcoming ...

Oppenheimer analyst Ian Zaffino maintained a Buy rating on Talen Energy Corp (TLN – Research Report) today and set a price target of ...

BridgeBio Pharma BBIO) stock received a Perform rating from Oppenheimer on market challenges to its late-stage assets acoramidis and infigratinib. Read more here.